SHANGHAI, Feb. 8, 2023
/PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the
"Company"), a platform-based internet technology company offering
services to patients with oncology and other major diseases, today
announced the application of ChatGPT (Chat Generative Pre-trained
Transformer) for content creation and patient interactions to
enhance the capabilities in delivering quality experience of
patient management services. ChatGPT is a language model developed
by OpenAI that learns and produces conversational content through
natural language processing powered by artificial intelligence
technology to interact with users in chat and continuously learn to
improve the user experience.
The Sunshine Health Forums and Zhongxin, both operated by
the PRC operating entities that Zhongchao consolidates the
financial statements with through certain contractual agreements,
provide medical knowledge education and treatment process
management services with patients through a comprehensive array of
resources, including media matrix, anti-cancer encyclopedia, online
consultation, and medication management. These platforms offer
patients with instant answers and clarifications for complex and
professional issues and questions encountered during
self-diagnosis, diagnostic and treatment process, serving as a
valuable reference for patients' consultation, treatment, and
health maintenance. Given the wide variety of human diseases and
the huge amount of medical information, patient management requires
efficient production of massive medical content and prompt patient
interactions. In a further effort to enhance patient experience,
Zhongchao will apply ChatGPT on the existing platforms of Wechat
Public Account and Mini-Program on WeChat to improve the efficiency
of producing graphics, videos, and other contents, promptly respond
and interact with patients, and manage patient emotions and
experiences. Zhongchao places a strong emphasis on delivering a
superior patient experience. In addition, patients will be alerted
that contents provided by ChatGPT will be solely for reference and
convenience to users and shall not be relied on for diagnostic or
treatment purposes. To address patients' demand for personalized
services, the Company may plan to harness ChatGPT's power of
advanced thinking and computing capabilities to develop customized
disease management models and intelligent tools that cater to the
specific needs and conditions of each patient, ensuring patients
receiving individualized and tailored services regardless of their
varying disease types, stages, health conditions, and mental
states.
Weiguang Yang, Chairman and Chief
Executive Officer of Zhongchao, commented, "as a platform-based
internet technology company, Zhongchao is steadfast in its
commitment to leveraging innovative information technology to
develop patient education models and management tools to improve
the effectiveness and efficiency of patient management. We believe
that the Company's application of ChatGPT to patient education and
management will greatly enhance patient service experience and open
up new avenues for growth in the patient-related business. Moving
forward, we will continue to explore the full potential of ChatGPT
and evaluate other emerging technologies to providing advanced
solutions to enhance patient experience."
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in
the Cayman Islands. It conducts
operations in China through the
contractual arrangements between its wholly owned subsidiary and
PRC operating entities. Zhongchao Inc. is a platform-based internet
technology company offering services to patients with oncology and
other major diseases. The PRC operating entities provide online
healthcare information, professional training and educational
services to healthcare professionals under their "MDMOOC" platform
(www.mdmooc.org), offer patient management services in the
professional field of tumor and rare diseases through Zhongxin,
offer internet healthcare services through Zhixun Internet
Hospital, and pharmaceutical services through Xinjiang Medical and
operate an online information platform, Sunshine Health Forums, to
general public. More information about the Company can be found at
its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's
future business development; product and service demand and
acceptance; changes in technology; economic conditions; the growth
of the professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 21-3220-5987
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:https://www.prnewswire.com/news-releases/zhongchao-inc-announces-the-application-of-chatgpt-to-elevate-patient-management-service-capabilities-and-experience-301741353.html
SOURCE Zhongchao Inc.
